McDougall, B <br/><br/>
Dicaffeoylquinic and dicaffeoyltartaric acids are selective inhibitors of human immunodeficiency virus type 1 integrase.  [electronic resource] 

 -  Antimicrobial agents and chemotherapy  Jan 1998 
 - 140-6 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0066-4804 
<br/><br/><label>Standard No.: </label>10.1128/AAC.42.1.140  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acquired Immunodeficiency Syndrome--drug therapy<br/>Caffeic Acids<br/>Chlorogenic Acid--analogs & derivatives<br/>Cinnamates--pharmacology<br/>HIV Envelope Protein gp120--drug effects<br/>HIV Integrase--drug effects<br/>HIV Integrase Inhibitors--pharmacology<br/>HIV Reverse Transcriptase--drug effects<br/>HIV-1--drug effects<br/>Humans<br/>Succinates<br/>Tartrates--pharmacology